CIK: 0001687078 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $643,507 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | 7,648,268 | $133,386 | 20.7% | $40.60 | -47.5% | Common | 230031106 |
| INSM | Insmed Incorporated | 615,391 | $41,231 | 6.4% | $21.93 | +76.9% | Common | 457669307 |
| OLMA | Olema Pharmaceuticals, Inc. | 2,654,867 | $28,726 | 4.5% | $9.74 | +11.3% | Common | 68062P106 |
| — | iTeos Therapeutics, Inc. | 1,745,943 | $25,910 | 4.0% | $24.67 | — | Common | 46565G104 |
| CRNX | Crinetics Pharmaceuticals Inc. | 557,184 | $24,956 | 3.9% | $24.65 | +87.3% | Common | 22663K107 |
| MDGL | Madrigal Pharmaceuticals inc | 71,185 | $19,943 | 3.1% | $178.79 | +33.1% | Common | 558868105 |
| IOVA | Iovance Biotherapeutics Inc | 2,366,714 | $18,981 | 2.9% | $10.03 | +6.8% | Common | 462260100 |
| NTRA | Natera Inc | 174,811 | $18,930 | 2.9% | $75.58 | +34.4% | Common | 632307104 |
| MIRM | Mirum Pharmaceuticals Inc | 492,569 | $16,841 | 2.6% | $26.22 | 0.0% | Common | 604749101 |
| RARE | Ultragenyx Pharmaceutical Inc | 380,552 | $15,641 | 2.4% | $45.58 | -6.3% | Common | 90400D108 |
| MLTX | Moonlake Immunotherapeutics | 343,235 | $15,092 | 2.3% | $29.03 | +45.9% | Class A Ord | 61559X104 |
| GH | Guardant Health Inc | 500,000 | $14,440 | 2.2% | $23.27 | 0.0% | Common | 40131M109 |
| IRON | Disc Medicine Inc | 305,658 | $13,776 | 2.1% | $42.93 | -20.9% | Common | 254604101 |
| ALKS | Alkermes Plc | 557,556 | $13,437 | 2.1% | $24.53 | 0.0% | Common | G01767105 |
| EWTX | Edgewise Therapeutics Inc | 740,661 | $13,339 | 2.1% | $16.52 | +5.6% | Common | 28036F105 |
| ALXO | ALX Oncology Holdings Inc. | 2,180,864 | $13,151 | 2.0% | $10.66 | +15.3% | Common | 00166B105 |
| — | MORPHIC HOLDING INC | 369,384 | $12,585 | 2.0% | $26.25 | — | Common | 61775R105 |
| LNTH | Lantheus Holdings Inc | 150,000 | $12,044 | 1.9% | $73.36 | 0.0% | Common | 516544103 |
| RVMD | Revolution Medicines, Inc. | 289,396 | $11,231 | 1.7% | $27.55 | +35.6% | Common | 76155X100 |
| — | Avadel Pharmaceuticals PLC | 783,242 | $11,012 | 1.7% | $14.59 | — | Sponsored ADR | 05337M104 |
| XERS | Xeris Biopharma Holdings Inc | 4,830,526 | $10,869 | 1.7% | $2.48 | -18.6% | Common | 98422E103 |
| AXSM | Axsome Therapeutics, Inc. | 132,312 | $10,651 | 1.7% | $68.79 | +7.6% | Common | 05464T104 |
| KALV | Kalvista Pharmaceuticals Inc | 881,937 | $10,389 | 1.6% | $13.10 | -10.9% | Common | 483497103 |
| NTLA | Intellia Therapeutics, Inc. | 443,503 | $9,926 | 1.5% | $70.53 | -66.2% | Common | 45826J105 |
| — | Hillevax Inc | 645,085 | $9,328 | 1.4% | $14.46 | — | Common | 43157M102 |
| — | Akero Therapeutics Inc | 385,990 | $9,055 | 1.4% | $25.01 | — | Common | 00973Y108 |
| — | 89Bio Inc | 1,121,736 | $8,985 | 1.4% | $11.14 | — | Common | 282559103 |
| FULC | Fulcrum Therapeutics Inc | 1,444,851 | $8,958 | 1.4% | $8.64 | -12.3% | Common | 359616109 |
| — | Sutro Biopharma, Inc. | 3,043,346 | $8,917 | 1.4% | $5.65 | — | Common | 869367102 |
| SRRK | Scholar Rock Holding Corp | 1,028,330 | $8,566 | 1.3% | $12.23 | 0.0% | Common | 80706P103 |
| RLAY | Relay Therapeutics Inc. | 1,274,459 | $8,309 | 1.3% | $13.74 | -50.3% | Common | 75943R102 |
| RNAC | Cartesian Therapeutics Inc | 259,696 | $7,014 | 1.1% | $23.87 | 0.0% | Common | 816212302 |
| RGNX | REGENXBIO Inc. | 557,076 | $6,518 | 1.0% | $28.86 | -46.1% | Common | 75901B107 |
| VKTX | VIKING THERAPEUTICS INC | 118,960 | $6,306 | 1.0% | $14.30 | +358.3% | Common | 92686J106 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 1,450,000 | $5,931 | 0.9% | $13.75 | -18.8% | Common | 98943L107 |
| HOWL | Werewolf Therapeutics, Inc. | 2,388,011 | $5,827 | 0.9% | $13.70 | -64.9% | Common | 95075A107 |
| — | Repare Therapeutics, Inc. | 1,639,849 | $5,412 | 0.8% | $31.02 | — | Common | 760273102 |
| RNAM | Avidity Biosciences Inc | 125,000 | $5,106 | 0.8% | $28.69 | 0.0% | Common | 05370A108 |
| CMPX | Compass Therapeutics, Inc. | 5,005,086 | $5,005 | 0.8% | $1.57 | -6.7% | Common | 20454B104 |
| ADAPY | Adaptimmune Therapeutics plc | 5,095,912 | $4,969 | 0.8% | $0.93 | — | Sponsored ADR | 00653A107 |
| IMTX | Immatics NV | 417,810 | $4,855 | 0.8% | $11.27 | 0.0% | Common | N44445109 |
| TRVI | Trevi Therapeutics Inc | 1,510,174 | $4,500 | 0.7% | $2.29 | +21.2% | Common | 89532M101 |
| — | Verve Therapeutics, Inc | 638,163 | $3,114 | 0.5% | $30.36 | — | Common | 92539P101 |
| — | Allakos | 344,900 | $345 | 0.1% | $1.00 | — | Common | 01671P100 |